ZTS Zoetis Inc
Company Analysis
Latest News
Zoetis Sued for Misleading Investors, Citing Librela Safety and Market Loss
The Schall Law Firm and DJS Law Group filed a securities class action lawsuit against Zoetis Inc. The legal action covers the period between January 14, 2025,...
🟢 Zoetis Inc is trading 4% up today in relief rebound from recent litigation-driven pressure
Zoetis Inc is trading 4% up at $81.98 in a relief rebound following recent pressure tied to litigation headlines and weakness in prior sessions. • The stock...
Zoetis Downgraded by Argus Amid Competitive Pressures
Argus Research downgraded Zoetis Inc. to 'Hold' from 'Buy'. The firm cited increased competition, shifting animal health market demand, and margin...
Zoetis Sued Over Misleading Pet Drug Claims, Following 21.5% Stock Drop
Labaton Keller Sucharow LLP filed a securities class action lawsuit against Zoetis Inc. and its executives. The suit alleges the company made false and...
Zoetis first quarter 2026 earnings miss estimates as U.S. pet care sales decline 11%
Zoetis reported first quarter 2026 revenue of $2.3 billion, up 3% year-over-year, and adjusted EPS of $1.53, missing analyst estimates of $1.61. The...
Zoetis Inc Q1 2026 Earnings Preview: What Analysts Expect on May 07, 2026
Analysts expect Zoetis to report Q1 2026 revenue of $2.30 billion and earnings per share of $1.61, as the stock currently trades at $116.91 compared to an...